uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Graspa
Application withdrawn
Human
Orphan medicine
Details
EMA number
EMEA/H/C/004055
ATC code
L01
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of acute lymphoblastic leukaemia.
MeSH:
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Group:
Antineoplastic agents
Active substances
asparaginase
Marketing Authorisation Holder
ERYTECH Pharma S.A.
MAH
Timeline
Filter by authority:
EMA
Graspa authorised
27 Jun 2018
authorised
regulatory
Graspa | uMedical